Access the full text.
Sign up today, get DeepDyve free for 14 days.
Manuel Franco, H. Greenberg (1995)
Role of B cells and cytotoxic T lymphocytes in clearance of and immunity to rotavirus infection in miceJournal of Virology, 69
J. Plana-Durán, M. Bastons, M. Rodríguez, I. Climent, E. Cortés, C. Vela, I. Casal (2005)
Oral immunization of rabbits with VP60 particles confers protection against rabbit hemorrhagic diseaseArchives of Virology, 141
M. Niikura, S. Takamura, Gisen Kim, S. Kawai, M. Saijo, S. Morikawa, I. Kurane, Tiancheng Li, N. Takeda, Y. Yasutomi (2002)
Chimeric recombinant hepatitis E virus-like particles as an oral vaccine vehicle presenting foreign epitopes.Virology, 293 2
Mary Estes, J. Ball, S. Crawford, C. O’Neal, Antone Opekun, David Graham, M. Conner (1997)
Virus-like particle vaccines for mucosal immunization.Advances in experimental medicine and biology, 412
M. Estes, S. Crawford, M. Penaranda, B. Petrie, J. Burns, W. Chan, B. Ericson, G. Smith, M. Summers (1987)
Synthesis and immunogenicity of the rotavirus major capsid antigen using a baculovirus expression systemJournal of Virology, 61
R. Ward, D. Bernstein, Rakesh Shukla, E. Young, J. Sherwood, M. McNeal, M. Walker, G. Schiff (1989)
Effects of antibody to rotavirus on protection of adults challenged with a human rotavirus.The Journal of infectious diseases, 159 1
S. Periwal, Kristin Kourie, Nandini Ramachandaran, Susan Blakeney, Sylvia DeBruin, Duzhang Zhu, T. Zamb, Larry Smith, S. Udem, J. Eldridge, K. Shroff, P. Reilly (2003)
A modified cholera holotoxin CT-E29H enhances systemic and mucosal immune responses to recombinant Norwalk virus-virus like particle vaccine.Vaccine, 21 5-6
Q. Yao, V. Vuong, Min Li, R. Compans (2002)
Intranasal immunization with SIV virus-like particles (VLPs) elicits systemic and mucosal immunity.Vaccine, 20 19-20
S. Crawford, M. Labbé, Jean Cohen, M. Burroughs, Yong-jie Zhou, M. Estes (1994)
Characterization of virus-like particles produced by the expression of rotavirus capsid proteins in insect cellsJournal of Virology, 68
B. Kim, T. Bowersock, P. Griebel, A. Kidane, L. Babiuk, M. Sanchez, S. Attah-poku, R. Kaushik, G. Mutwiri (2002)
Mucosal immune responses following oral immunization with rotavirus antigens encapsulated in alginate microspheres.Journal of controlled release : official journal of the Controlled Release Society, 85 1-3
C. O’Neal, J. Clements, M. Estes, M. Conner (1998)
Rotavirus 2/6 Viruslike Particles Administered Intranasally with Cholera Toxin, Escherichia coli Heat-Labile Toxin (LT), and LT-R192G Induce Protection from Rotavirus ChallengeJournal of Virology, 72
A. Charpilienne, M. Nejmeddine, M. Berois, N. Parez, E. Neumann, E. Hewat, G. Trugnan, Jean Cohen (2001)
Individual Rotavirus-like Particles Containing 120 Molecules of Fluorescent Protein Are Visible in Living Cells* 210The Journal of Biological Chemistry, 276
J. Taylor, J. Meyer, M. Legge, J. O'Brien, J. Street, V. Lord, C. Bergmann, A. Bellamy (1992)
Transient expression and mutational analysis of the rotavirus intracellular receptor: the C-terminal methionine residue is essential for ligand bindingJournal of Virology, 66
T. French, P. Roy (1990)
Synthesis of bluetongue virus (BTV) corelike particles by a recombinant baculovirus expressing the two major structural core proteins of BTVJournal of Virology, 64
A. Choi, D. Knowlton, M. McNeal, R. Ward (1997)
Particle bombardment-mediated DNA vaccination with rotavirus VP6 induces high levels of serum rotavirus IgG but fails to protect mice against challenge.Virology, 232 1
S. Haas, J. Miura-Fraboni, F. Zavala, K. Murata, A. Leone-Bay, N. Santiago (1996)
Oral immunization with a model protein entrapped in microspheres prepared from derivatized alpha-amino acids.Vaccine, 14 8
C. O’Neal, S. Crawford, M. Estes, M. Conner (1997)
Rotavirus virus-like particles administered mucosally induce protective immunityJournal of Virology, 71
A. Coste, J. Cohen, M. Reinhardt, J. Kraehenbuhl, J. Sirard (2001)
Nasal immunisation with Salmonella typhimurium producing rotavirus VP2 and VP6 antigens stimulates specific antibody response in serum and milk but fails to protect offspring.Vaccine, 19 30
H. Madore, M. Estes, C. Zarley, B. Hu, S. Parsons, D. Digravio, S. Greiner, R. Smith, B. Jiang, B. Corsaro, V. Barniak, S. Crawford, M. Conner (1999)
Biochemical and immunologic comparison of virus-like particles for a rotavirus subunit vaccine.Vaccine, 17 19
A. Charpilienne, J. Lepault, F. Rey, Jean Cohen (2002)
Identification of Rotavirus VP6 Residues Located at the Interface with VP2 That Are Essential for Capsid Assembly and Transcriptase ActivityJournal of Virology, 76
G. O'Brien, Catherine Bryant, Charlotte Voogd, H. Greenberg, R. Gardner, A. Bellamy (2000)
Rotavirus VP6 expressed by PVX vectors in Nicotiana benthamiana coats PVX rods and also assembles into viruslike particles.Virology, 270 2
B. Jiang, M. Estes, C. Barone, V. Barniak, C. O’Neal, A. Ottaiano, H. Madore, M. Conner (1999)
Heterotypic protection from rotavirus infection in mice vaccinated with virus-like particles.Vaccine, 17 7-8
X. Liang, Lamm Me, Nedrud Jg (1989)
Cholera toxin as a mucosal adjuvant for respiratory antibody responses in mice.Regional immunology, 2 4
C. Reitsma, D. Henning, C. Chase, D. Hurley (1997)
Mechanisms in the Pathogenesis of Enteric Diseases
A. Choi, M. Basu, M. Rae, M. McNeal, R. Ward (1998)
Particle-bombardment-mediated DNA vaccination with rotavirus VP4 or VP7 induces high levels of serum rotavirus IgG but fails to protect mice against challenge.Virology, 250 1
M. Ciarlet, S. Crawford, C. Barone, Andrea Bertolotti-Ciarlet, R. Ramig, M. Estes, M. Conner (1998)
Subunit Rotavirus Vaccine Administered Parenterally to Rabbits Induces Active Protective ImmunityJournal of Virology, 72
Andrea Bertolotti-Ciarlet, M. Ciarlet, S. Crawford, M. Conner, M. Estes (2003)
Immunogenicity and protective efficacy of rotavirus 2/6-virus-like particles produced by a dual baculovirus expression vector and administered intramuscularly, intranasally, or orally to mice.Vaccine, 21 25-26
M. McNeal, M. Rae, J. Bean, R. Ward (1999)
Antibody-Dependent and -Independent Protection following Intranasal Immunization of Mice with Rotavirus ParticlesJournal of Virology, 73
C. Elson (1996)
4 – Cholera Toxin as a Mucosal Adjuvant
P. Awram, R. Gardner, R. Forster, A.Richard Bellamy (2002)
The potential of plant viral vectors and transgenic plants for subunit vaccine production.Advances in virus research, 58
K. Yang, S. Wang, K. Chang, S. Lu, L. Saif, H. Greenberg, J. Brinker, J. Herrmann (2001)
Immune responses and protection obtained with rotavirus VP6 DNA vaccines given by intramuscular injection.Vaccine, 19 23-24
Z. Xiang, H. Ertl (1999)
Induction of mucosal immunity with a replication-defective adenoviral recombinant.Vaccine, 17 15-16
We examined the use of a virus-like particle (VLP) as an immunogen by analysing the IgA and IgG response generated in serum, intestinal (fecal), pulmonary and uterine samples. The particle comprised two rotavirus capsid proteins (simian VP2 and murine VP6) generated using recombinant baculovirus expression of the two capsid proteins, which self-assembled into particulate VLP2/6. Mice were immunized orally or intraperitoneally (i.p.) with 0 or 100 µg VLP2/6 with or without 5 µg cholera toxin adjuvant. The results showed a systemic and mucosal immune response to VLP2/6 when administered i.p. and, to a lesser extent, when delivered orally which was not dependant on adjuvant use and further proves the concept of VLP2/6 as an effective immunogen.
Archives of Virology – Springer Journals
Published: Feb 1, 2005
Read and print from thousands of top scholarly journals.
Already have an account? Log in
Bookmark this article. You can see your Bookmarks on your DeepDyve Library.
To save an article, log in first, or sign up for a DeepDyve account if you don’t already have one.
Copy and paste the desired citation format or use the link below to download a file formatted for EndNote
Access the full text.
Sign up today, get DeepDyve free for 14 days.
All DeepDyve websites use cookies to improve your online experience. They were placed on your computer when you launched this website. You can change your cookie settings through your browser.